Evidence map›Paper›PMID 37143985›Full record

ArticleFrontiers in public health2023

Prevalence, incidence, and mortality rates of breast cancer in Kazakhstan: data from the Unified National Electronic Health System, 2014-2019.

Anna Midlenko, Kamilla Mussina, Gulnur Zhakhina, Yesbolat Sakko, Gyunel Rashidova, Bolat Saktashev, Dauren Adilbay, Oxana Shatkovskaya, Abduzhappar Gaipov

Abstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. RSC advances · 2024
    Article
  9. Article
  10. Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021.International journal of health policy and management · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna Midlenko *Department of Surgery, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Kamilla Mussina *Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Gulnur ZhakhinaDepartment of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Yesbolat SakkoDepartment of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Gyunel RashidovaSchool of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.
Bolat SaktashevDepartment of Mammology, Oncological Center of Tomotherapy "UMIT", Astana, Kazakhstan.
Dauren AdilbayDepartment of Otolaryngology Head and Neck Surgery, Louisiana State University Health Sciences, Shreveport, LA, United States.
Oxana ShatkovskayaDepartment of Scientific and Strategic Activities, Kazakh Research Institute of Oncology and Radiology, Almaty, Kazakhstan.
Abduzhappar GaipovDepartment of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although there are numerous sources of epidemiologic information on breast cancer in Kazakhstan, none of them have specifically examined the burden of this disease. Therefore, this article aims to provide an overview of the breast cancer prevalence, incidence, mortality, and distribution and changes over time in Kazakhstan based on nationwide large-scale healthcare data from the National Registry in order to encourage more research on the impact of various diseases at the regional and national levels. Methods: The study cohort included all adult women older than 25 years who were diagnosed with breast cancer in any clinical setting of the Republic of Kazakhstan during the period of 2014-2019. The data were extracted from the Unified Nationwide Electronic Health System (UNEHS) to get an overview of descriptive statistics, incidence, prevalence, and mortality rate calculations and the Cox proportional hazards regression model. All survival functions and factors associated with mortality were tested for significance. Results: The cohort population ( Conclusion: Overall, Kazakhstan is experiencing an increase in the incidence of breast cancer cases, but the mortality rate has started to decline. The switch to population mammography screening could reduce the breast cancer mortality rate. These findings should be utilized to help Kazakhstan determine what cancer control priorities should be utilized, including the need to implement efficient and affordable screening and prevention programs.

Indexed as

Breast NeoplasmsAdultAgedAged, 80 and overFemaleHumansIncidenceKazakhstanMammographyMiddle AgedPrevalencebreast cancerincidenceKazakhstanKazakhstan breast cancermortalityprevalence

Identifiers

PMID37143985
PMCPMC10153091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.